bepridil has been researched along with Graves Disease in 1 studies
Bepridil: A long-acting calcium-blocking agent with significant anti-anginal activity. The drug produces significant coronary vasodilation and modest peripheral effects. It has antihypertensive and selective anti-arrhythmia activities and acts as a calmodulin antagonist.
bepridil : A tertiary amine in which the substituents on nitrogen are benzyl, phenyl and 3-(2-methylpropoxy)-2-(pyrrolidin-1-yl)propyl.
Graves Disease: A common form of hyperthyroidism with a diffuse hyperplastic GOITER. It is an autoimmune disorder that produces antibodies against the THYROID STIMULATING HORMONE RECEPTOR. These autoantibodies activate the TSH receptor, thereby stimulating the THYROID GLAND and hypersecretion of THYROID HORMONES. These autoantibodies can also affect the eyes (GRAVES OPHTHALMOPATHY) and the skin (Graves dermopathy).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kunii, Y | 1 |
| Uruno, T | 1 |
| Matsumoto, M | 1 |
| Mukasa, K | 1 |
| Noh, J | 1 |
| Ito, K | 1 |
| Akaishi, M | 1 |
| Hori, S | 1 |
| Nakazawa, H | 1 |
1 other study available for bepridil and Graves Disease
| Article | Year |
|---|---|
Pharmacological conversion of atrial fibrillation in the patients of Graves' disease.
Topics: Administration, Oral; Adult; Atrial Fibrillation; Bepridil; Calcium Channel Blockers; Female; Graves | 2012 |